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Abstract
Understanding the regulation of retinal synapses is a key step in elucidating the
processing of information in the retina. Our lab has previously shown that nitric oxide (NO) can
alter the synaptic response properties of amacrine cells by releasing Cl- from internal acidic
compartments. This alteration in the Cl- gradient brings about a positive shift in the reversal
potential of the GABA-gated current, which can convert inhibitory synapses into excitatory
synapses. Recently, we have shown that the cystic fibrosis transmembrane regulator (CFTR) Clchannel is involved in the Cl- release. Here, we test the hypothesis that (acidic) synaptic vesicles
are a source of NO-releasable Cl- in chick retinal amacrine cells. If SVs are a source of Cl-, then
depleting synaptic vesicles should decrease the NO-dependent shift in the reversal potential of
the GABA-gated current. The efficacy of four inhibitors of dynamin (a GTPase required for
some forms of endocytosis) were evaluated. In order to deplete synaptic vesicles, voltage-steps
were used to activate voltage-gated Ca2+ channels and stimulate the synaptic vesicle cycle either
under control conditions or after treatment with the dynamin inhibitors. Voltage-ramps were used
to measure the NO-dependent shift in the reversal potential of the GABA-gated currents under
both conditions. Our results reveal that activating the synaptic vesicle cycle in the presence of
dynasore and dyngo 4a blocked the NO-dependent shift in Erev-GABA. However, we also
discovered that some dynamin inhibitors reduced Ca2+ signaling and L-type Ca2+ currents.
Conversely, dynasore also increased neurotransmitter release at autaptic sites. To try to resolve
the mechanism underlying the inhibition of the NO-dependent shift in the reversal potential for
the GABA-gated currents, and to verify the effects of inhibiting endocytosis on the NOdependent release of Cl-, we also tested the effects of the clathrin assembly inhibitor Pitstop 2
and found that this compound also inhibited the shift. These data provide evidence that dynamin
ix

inhibitors have multiple effects on amacrine cell synaptic transmission. These data also suggest
that inhibition of endocytosis disrupts the ability of NO to elicit Cl- release from internal stores,
which may in part be due to depletion of synaptic vesicles.
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Chapter 1. Introduction
Chemical synaptic transmission is a key method of communication between neurons. It is
the process through which neurotransmitter is released from presynaptic neuronal terminals and
binds to receptors on postsynaptic neurons. The release and subsequent binding of
neurotransmitter to receptor can lead to excitatory or inhibitory responses, depending on the
ionic permeability and the equilibrium potential of the most permeant ion for the postsynaptic
receptors. Chemical synapses, via secretion of neurotransmitters, are especially important
because of the diversity in physiological types of synapses and their flexibility can alter the
transmission of information to the postsynaptic cell. The transmission of information through
neuronal circuits depends on the function and regulation of synapses. For example, generally,
when the neurotransmitter γ-Aminobutyric acid (GABA) is released from a presynaptic cell in
the CNS, where it binds to either GABAA, GABAB, or GABAC postsynaptic receptors. Binding
to the ionotropic GABAA or GABAC receptors triggers the channel to open and ions (Cl- or
bicarbonate) to flow into the cytoplasm of the cell which usually, though not always [1, 2]
triggers an inhibitory response (termed ‘rapid’ or ‘phasic’ inhibition)[3]. However, GABAA
receptors can also assemble extrasynaptically (tonic inhibition) [4-8] in which they can have
various effects on granule cells [9], thalamocortical relay neurons [10], layer V pyramidal
neurons [11], CA1 pyramidal cells [12] and a small class of inhibitory hippocampal CA1
interneurons [13].
Conversely, metabotropic GABAB receptors are G-coupled receptors that activate
enzymes (for example, phospholipase C and adenylate cyclase) that generate second messengers
[14]. GABAB receptor-activated responses are slower and more prolonged than its ionotropic
counterparts. Furthermore, GABAB receptors are localized at pre- and postsynaptic sites, and the
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variability in the number of receptors and the downstream effects of receptor signaling regulates
the level of that cell’s synaptic inhibition. For example, presynaptic GABAB receptors inhibit
Ca2+ channel activity [15, 16], while postsynaptic receptor activity can produce slow inhibitory
postsynaptic potentials via g-protein inwardly rectifying K+ channel (GIRK) activation [17-19].
GABAB receptor activation can also modulate Glutamate receptor function [20]. Interestingly,
our lab uncovered a mechanism by which activation of metabotropic glutamate receptors
(mGluR) with the mGluR-5 specific agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) can
enhance GABAA receptor current amplitudes in retinal amacrine cells [21]. Taken together,
GABA receptors have a wide range of means to regulate inhibitory and excitatory
neurotransmission.
Our lab focuses on the study of synaptic transmission at chemical synapses between
vertebrate retinal neurons, specifically amacrine cells (ACs). ACs are interneurons that primarily
mediate inhibitory interactions within the inner retina. We have previously shown that nitric
oxide (NO), a gaseous signaling molecule, can alter the response properties of postsynaptic ACs
that express chloride (Cl-) conducting γ-Aminobutyric acid (GABAA) receptors. Specifically, a
unique mechanism involves a NO-dependent release of Cl- from internal stores into the
cytoplasm [22]. This release brings about a positive shift of the equilibrium potential for the
GABA-gated current (EGABA), which can convert GABAergic and glycinergic inhibitory
synapses into excitatory synapses (Figure 1.1).
Endosomes are strong candidates for being the source of this NO-releasable Cl- because
they contain millimolar (mM) concentrations of Cl-.
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Figure 1.1: NO inverts the sign of GABAergic synapses. Current clamp recordings from a
postsynaptic amacrine cell. Depolarization of the presynaptic cell from -70 mV to 0 mV (in
voltage clamp) produces only a small hyperpolarization in the postsynaptic cell (black trace)
because the resting potential of this cell (-67mV) is near the predicted ECl- (-70 mV). A record
collected after the NO exposure reveals a depolarization in the postsynaptic cell (red trace). Scale
bars are 5 mV, 100 ms (From Hoffpauir et al., 2006).
Furthermore, the Cl- concentration correlates with an acidic luminal pH [23]. Our lab has
demonstrated a link between fluctuations in cytosolic pH and Cl- in retinal ACs [24].
Additionally, we have provided evidence suggesting that Cl- is released from acidic organelles,
and that intact endosomal proton gradients are required for the NO-dependent release of Cl- [25].
The Retina: Structure & Function
The retina is a layer of neural tissue that is responsible for processing visual information
and relaying that information to the optic nerve and eventually to the brain. In the outer nuclear
layer (ONL) of the retina, photoreceptors hyperpolarize after detecting photons, thus converting
photon arrival into electrical signals. This electrical information is then transmitted through
multiple pathways from the outer plexiform layer (OPL), through the inner retina which includes
the inner plexiform layer (IPL) and inner nuclear layer (INL). This signal then reaches the
ganglion cell layer (GCL), where ganglion cell axons extend into the optic nerve. In the inner
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retina, 3 classes of interneurons convey and refine visual information before transferring the
signal to ganglion cells: bipolar cells, horizontal cells, and ACs (Figure 1.2), [26]. Our
experiments exclusively investigate synaptic responses in ACs.

Figure 1.2: Neuronal organization of the retina. Rods and Cones initiate the cascade of visual
information transmission by forming synapses onto bipolar cells (ONL = outer nuclear layer).
Horizontal cells modulate the flow of electrical signal within these synapses (OPL = outer
plexiform layer). ACs synapse onto bipolar cells, ganglion cells (GCL = ganglion cell layer), and
other ACs (INL = inner nuclear layer) to mediate transmission within the inner retina.

Retinal ACs: Diversity and Functions
ACs are characterized by their diversity of morphology, stratification pattern, and
functions. GABAergic ACs are likely to be especially important because their GABAergic
synapses account for about 92% [27] of conventional inhibitory synapses within the inner retina.
The remaining inhibitory synapses are mainly supplied by glycinergic synapses such as those
common to the narrow-field subtype of ACs [28, 29]. There are estimated 30-40 morphological
types of ACs, most of which can be divided into three broad morphological categories: narrow-,
medium-, and wide-field (Figure 1.3).
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Figure 1.3: Examples of narrow- (NF), medium- (MF), and wide-field (WF) ACs. Narrow field
ACs have smaller lateral spread (about 30-125 μm). Medium field ACs extend farther (~125-400
μm) and wide field (WF) ACs extend their processes farther than ~400 μm.
Surveys of AC types in the retina revealed that the medium- and wide field ACs most
commonly form GABAergic synapses within the inner retina [30]. The majority of ACs are
axon-less neurons that signal with graded potentials. However, there is a population of axon
bearing wide-field ACs that fire action potentials to carry the signal down the axon to
neurotransmitter release sites [31] [32]. Most ACs, however, extend dendrites into the inner
plexiform layer (IPL) of the retina that are both presynaptic and postsynaptic capable. This is
possible because AC dendrites have both presynaptic sites and receptors for the binding of
neurotransmitters released from other neurons.
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Although there are potentially many functions of ACs, the most well-known are: general
object motion detection (a computational relationship between ACs and ganglion cells), vertical
synaptic information integration (a result of dendrite stratifications to many layers of the INL),
and crossover inhibition (transmitting ON- and OFF-bipolar cell information bi-directionally),
[26]. Consequently, understanding the regulation and functions of AC synapses is instrumental in
decoding how visual information is transmitted in the retina.
A number of ACs perform narrowly specified functions. For example, the A17 type of
AC provides inhibitory feedback to rod bipolar cells through hundreds of independent
microcircuits [33]. This is the A17’s primary, perhaps even sole, task and this function enhances
the reliability of information transmission during dim-light conditions. The starburst AC is
another example of an interneuron in the retina with a specified function. These ACs are named
for their particularly star-like dendritic arbor and provide directional selectivity to directionally
selective ganglion cells [34]. Dendritic sectors that point in a single direction exclusively synapse
on a direction-selective ganglion cell, and that sector acts independently from other dendrites
[35].
Some ACs also have a paracrine function. The most well documented example of this is
the dopaminergic AC. These cells use their wide diameter dendritic field to perform traditional
GABAergic synaptic release as well as diffusely co-release dopamine onto D1 and D2 receptors
of AII ACs in the IP. [36-38] In the rabbit retina, dopamine release from ACs can decrease
electrical coupling at gap junctions [39], and, in mice, this uncoupling can disrupt dim lighttriggered rod photoreceptor glutamate release onto ganglion cells. [40]
The wide array of morphologies and functions of ACs collaboratively fine-tune the visual
signal that is transmitted to ganglion cells, and then dispatched to higher visual centers for
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further processing. In these few examples, it is evident that AC diversity is prominent throughout
the retina. Understanding the regulation and function of the AC GABAergic synapse is
fundamental to understanding the functional visual circuits in the inner plexiform layer, as well
as understanding GABAergic synapses elsewhere in the CNS. The retinal culture system utilized
in our lab is a good model system for studying GABAergic AC synapses in the retina because
these cells express the same ligand-gated and voltage-gated ion channels found in ACs in the
intact chicken retina [41-43]. Therefore, the data that we collect provides valuable information
about the regulation of GABAergic AC synapses.

Local dendrite-dendrite signaling
Long since early electron microscopy imaging of the mammalian retina [44] the study of
the diversity of AC synapses has redefined conventional synaptic circuitries in GABAergic
neurons. In an extensive mapping of retinal micronetworks in the cyprinid retina, Marc & Liu
uncovered layers of bipolar cell, ganglion cell and AC circuitry involving topological dendritic
AC loops (Fig. 1.4). These complex circuits are far richer than previously described simple
feedforward and feedback inhibition [45].
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Figure 1.4: Forms of inverting feedback/feedforward signaling in ACs. A. Simple
feedback/feedforward signaling between a bipolar cell (BC), AC, and ganglion cell (GC) as
previously described (adapted from Marmarelis and Marmarelis, 1978). B. The addition of a
single inverting loop to the AC is described as ‘formal’ nested feedback/feedforward. C. Two
distinct AC segments, driven by a single BC, forms a nested feedback/feedforward circuit.
(Adapted from Marc & Liu, 2000)
Certain classes of ACs display very unique styles of synaptic modulation. In many
conventional AC synapses, GABA release is coupled to membrane depolarization by the
activation of voltage-gated Ca2+ channels. Voltage-gated Ca2+ channel activation or membrane
depolarization, however, is not required for GABA release in A17 ACs, and is instead dependent
upon activation of glutamatergic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors [46]. In the rat retina, A17 AC varicosities contain colocalized glutamatergic
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input and GABAergic output sites that enable the AC to respond to glutamate with a
depolarization that can drive release of GABA independently of the activity at other varicosities
[33]. This unique, localized synaptic control is possible due to the triggering of Ca2+-permeable
AMPA receptors [46] within the estimated 500 varicosities on a single A17 AC [47]. In one
study, a computer reconstructed model of the electrical properties of an A17 cell, built with
anatomical measurements from 3D electron microscopy reconstructions, revealed ≥ 50
electrically independent microcircuits within the dendritic tree of a single AC [33].
Other sophisticated approaches reveal more intricate local signaling abilities of Starburst
ACs (SACs). In the rabbit retina, the largest spike in two-photon fluorescence imaging
measuring [Ca2+] was observed towards the distal end (farthest from the soma) of dendrites of
SACs [48]. These dendrites also displayed independent and relatively complex directionselective Ca2+ responses and somatic voltage changes to visual stimuli. When a moving bar
entered the ACs surround region, a brief hyperpolarization was observed, followed by a
depolarization as the bar moved over the dendritic tree, and another brief hyperpolarization as
the bar exited the ACs surround region. The ability of ACs to respond locally and perhaps
independently of other circuitry reveals how precisely these cells can refine and respond to visual
stimuli. Local response of ACs to light or to neuromodulators illustrates the sophisticated nature
of synaptic transmission in the inner retina.

Nitric oxide in the retina
Nitric oxide (NO) is a gaseous molecule that is synthesized from the conversion of Larginine to L-citrulline by the enzyme nitric oxide synthase (NOS). Initially, it was reported that
NO targets its receptor soluble guanylate cyclase (sGC) [49, 50], and operates through the
second messenger cyclic guanosine monophosphate (cGMP) as well as protein kinase G (PKG)
9

[51, 52]. It has also been reported that in addition to NO functioning via sGC activation, the
concentration of NO at these synapses may only be in the low nanomolar range [53] [54] [55].
However, other literature indicates that NO also functions through S-nitrosylation, which is a
form of post-translational protein modification. NO functions via the S-nitrosylation mechanism
have been identified in the regulation of K+ channels [56-58], endocytosis by the GTPase
dynamin [59] and as well as other proteins and receptors [60-62]. Recently, light-intensity
dependent S-nitrosylation has been demonstrated in goldfish and mouse retinas. In this study,
over 300 proteins were nitrosylated, which was reflected by an increase in S-nitrosocysteine
immunofluorescence, including many known to have functions in retinal signal processing [63].
NO functioning by mechanisms outside of binding to sGC allows for new interpretations of how
NO modulates synaptic transmission. NO operating via S-nitrosylation, or some other unknown
pathway, could be the mechanism by which NO causes Cl- release we’ve observed in the chick
retina.
Nitric oxide synthase (NOS) has three isoforms, two of which exhibit expression
throughout the vertebrate retina [64-66]. Inducible NOS (iNOS or NOS III) is Ca2+-independent
and expressed in inflammatory and pathological states. Endothelial NOS (eNOS or NOS II) was
initially found in vascular endothelium. However, employing the NO-indicator
diaminofluorescin (DAF) imaging alongside eNOS-like immunocytochemistry, our lab has
demonstrated both eNOS and neuronal NOS (nNOS) expression throughout the avian retina [67].
We have also demonstrated that NO is produced endogenously in the chick retina [67]. Neuronal
NOS and eNOS are Ca2+/calmodulin-dependent. Neuronal NOS expression dominates neurons
of the central (CNS) and peripheral nervous systems (PNS). In addition to its expression in the
vertebrate retina, nNOS has been shown to be involved in visual responses [65, 66] [68, 69].
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Three types of NO synthesizing ACs (NOACs) and their morphological properties have been
identified in the chick retina [70], mouse, and rat retinas [29, 71, 72]. NOACs have also been
identified in the turtle, which shares a common ancestor with the chicken [73]. Some NOACs
display distinct differences in somatic size, dendritic thickness and, interestingly, nonoverlapping expression of nNOS and eNOS immunoreactivity in the chick retina [67] [70, 74].
NO is involved in a wide range of physiological functions throughout the vertebrate retina and
CNS [75].

Nitric oxide’s effects on ACs
NO acts as a neuromodulator of GABA and glycine signaling, which are the major
inhibitory neurotransmitters of the retina. NO donors and cGMP analogs inhibit GABAA
receptor signaling via simultaneous up-regulation of PKG and down-regulation of protein kinase
A (PKA) in rat ACs [76]. Different concentrations of L-arginine, the NO precursor, produce
different effects on GABA release [77]. Interestingly in the chick retina, low concentrations (100
μM) caused an increase in GABA release from ACs, while higher concentrations (1 mM) caused
a decrease of GABA release from ACs residing in the GCL[78]. Furthermore, stimulation by the
NO donors NO amine complex (NOC-12) and S-Nitroso-N-acetylpenicillamine (SNAP) caused
an enhancement in GABAA receptor currents in chicken ACs [22, 79], which is contrary to what
was observed in the rat retina. The fact that NO can act in a biphasic manner provides evidence
that NO functions via multiple mechanistic pathways. In the chick retina, our lab has identified
an NO-dependent transient receptor potential canonical (TRPC5)-based mechanism by which a
Ca2+ influx can stimulate GABA release [80, 81]. Additionally, the function of NO as a
neuromodulator may depend on the species.
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The NO-dependent release of Cl- that the Gleason lab has discovered is essential to
understanding the regulation of GABAergic (and glycinergic) synaptic transmission in the
vertebrate retina. This release results in the shift of the equilibrium potential for Cl- (ECl-) to more
positive potentials, and a normally inhibitory synapse to become transiently less inhibitory or
even excitatory [22]. This transient switch of AC signaling via redistribution of internal Climplies that these GABAergic synapses could have dual functions in the inner retina. Whereby,
these synapses produce inhibition in postsynaptic ACs unless an NO signal is generated
converting the response from hyperpolarizing to depolarizing. Thus, NO could transiently
increase the inhibitory synaptic output from ACs.
Cl- - containing Endosomal Compartments & Cl- Dynamics
Acidification of intracellular organelles is critical to the normal development and
physiology of a cell. Acidification occurs via proton pumping by the vacuolar ATPase (VATPase), and this requires charge compensation by the counter ion Cl- to minimize the buildup
of a positive voltage that would oppose the proton pumping. These two processes work together
to establish transmembrane Cl- and pH gradients within the secretory pathways. Most of the
endosomal compartments have acidic interiors and the concentration of Cl- increases along with
pH decreases as vesicles transit through endosomal pathways. Synaptic vesicles (SVs) have a pH
of about 5.4 and 40 mM Cl-, late endosomes have a pH of 5.5 and 60, and lysosomes have an
estimated pH of 5.0 and 80 mM Cl- [82].
There is a wide range of ion exchangers along the endocytic pathway that varies
depending on the function of the endosome [83]. The chloride transporters expressed on
endosomes include the ClC family of chloride channels. ClCs 3-7 have been reported to be vital
to endosomal acidification and function as Cl-/H+ antiporters [84, 85]. ClCs 4-6 colocalize with
12

the SV marker SV2 in many layers of the chicken retina, which suggests that these transporters
could function at retinal synapses [24].
Recent evidence has emerged in our lab regarding the cystic fibrosis transmembrane
conductance regulator (CFTR), which is a cyclic AMP (cAMP)-activated Cl- channel originally
localized to the plasma membrane of epithelial cells [86]. CFTR can have diverse cellular
functions [87]. For example, CFTR operates as a regulator of synaptic Cl- in developing rat
motor neurons [88], promotes re-acidification of lysosomes in mouse retinal pigment epithelium
[89], and its interaction with the F-actin is required for proper channel function [90]. The
involvement of CFTR in the NO-dependent shift in Erev-GABA has been demonstrated in our lab
[91].

Synaptic Vesicle Endocytosis
Chemical synapses in the CNS are comprised of presynaptic and postsynaptic
specializations. At presynaptic terminals, exocytosis and compensatory endocytosis, or the SV
cycle, provides the plasma membrane redistribution that is necessary for neurotransmitter
loading, storage, and release. Clathrin is a cellular protein that is instrumental in many cellular
processes including endosomal sorting complex-required for transport (ESCRT)-dependent cargo
sorting [92], trans-Golgi network protein secretion [93], and mitosis [94]. At chemical synapses,
clathrin interacts with adaptor and cytoplasmic accessory proteins to form a coat around newly
endocytosed vesicles in what is known as clathrin-mediated endocytosis (CME). Although the
primary purpose of CME at neuronal synapses is SV formation, CME also regulates expression
of proteins in the plasma membrane, samples growth and guidance cues from the cell exterior,
coordinates the activation of signaling pathways, and redistributes membrane components [95].
A rich collaboration of SV and plasma membrane proteins direct the formation and assembly of
13

SVs. At endocytic sites, the GTPase dynamin primarily pinches off newly internalized
membrane to form clathrin-coated SVs. Dynamin and dynamin-like proteins also interact with
actin at membrane ruffles, within podosomes and invadopodia, and fission and fusion sites in the
endoplasmic reticulum [96]. Although there is evidence of clathrin-independent, dynamindependent pathways [97], targeting dynamin-dependent CME is a common tool for uncovering
the role SVs in synaptic transmission.
The intricacies of how AC synapses in the retina decipher the visual signal, the transient
yet significant response of ACs to NO signaling and its capacity to convert these inhibitory
synapses to excitatory, as well as the role of SVs in both remains obscure. The involvement of
acidic organelles in the NOdrCl [25], along with the requirement of CFTR in the NOdrCl [91],
provide the prelude for my research in Chapter 2. My work here indicates that inhibiting SVs
with dynamin inhibitors proposes an involvement of SVs to NOdrCl release in the chicken
retina.
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Chapter 2. Inhibition of Endocytosis Suppresses the Nitric Oxide-Dependent
Release of Cl- in Retinal ACs
The transmission of information through neuronal circuits depends on the function and
regulation of synapses. Chemical synapses are especially important because the diversity in the
physiological types of synapses and their flexibility can alter the conveyance of information. In
the vertebrate retina, amacrine cells (ACs) form primarily gamma-aminobutyric acid (GABA)ergic and glycinergic synapses with ganglion cells, bipolar cells, and other ACs. GABA and
glycine bind to ionotropic postsynaptic receptors and activate Cl- channels and the excitatory or
inhibitory effect of the postsynaptic response to these neurotransmitters is dependent upon the
electrochemical gradient for Cl- across the postsynaptic plasma membrane. Thus, understanding
the regulation of cytosolic Cl- at synapses is fundamental to understanding the full flexibility of
neuronal circuitry. We have previously shown that nitric oxide (NO), can alter the response
properties of postsynaptic ACs that express Cl- conducting GABA receptors. Specifically, a
novel mechanism involves a NO-dependent release of Cl- (NOdrCl) from internal stores into the
cytoplasm has been demonstrated [1] (Fig 2.1A). This release brings about a positive shift of the
equilibrium potential for Cl-, which can convert these GABAergic and inhibitory synapses into
excitatory synapses [1]. Endosomes are strong candidates for contributing to NO-releasable Clbecause they contain millimolar [2] concentrations of Cl-. Synaptic vesicles (SVs), derived from
early endosomes, have an estimated Cl- concentration of between 40-50 mM [3]. Additionally,
our lab has provided evidence that Cl- is released from acidic organelles, and that intact
endosomal proton gradients are required for the NOdrCl [4]. Acidification of endosomes occurs
via the simultaneous proton pumping of the V-ATPase and charge compensation by the counter
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ion Cl-, which is moved into the cytosol via a yet unknown Cl- transport mechanism. The cystic
fibrosis transmembrane conductance regulator (CFTR) is a Cl- transporter that can be found in
internal membranes of vertebrate neurons [5, 6].

Figure 2.1 Models for NO effects and the SV cycle. A: Cartoon depicting the factors determined
to be involved in the NOdrCl. Nitric Oxide causes an acidification of the cytosol and a release of
Cl- from acidic organelles. This effect of NO is dependent upon the expression and function of
CFTR. B. A simplified cartoon of the synaptic vesicle cycle. Here, we test the hypothesis that as
acidic organelles, SVs can be a source of NOdrCl, and that inhibition of dynamin could deplete
SVs.
Recently our lab has shown that pharmacological inhibition and knockdown of CFTR
expression in ACs blocks the NO-dependent shift in Erev-GABA [7]. Here we aim to test the
hypothesis that SVs can release Cl- and contribute to the NOdrCl. Nitric oxide synthase
expression is found in subsets of ACs in both mammalian [8-17]and avian retinas [18, 19] and
has been localized specifically to amacrine cell presynaptic terminals in the turtle retina[20].
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Furthermore, in the retina, ACs participate in reciprocal synapses with other ACs where pre and
postsynaptic elements within the same process can exist side by side [18, 19, 21-24]. As such,
Cl- released from SVs can influence the postsynaptic responses at adjacent synaptic sites. To
uncover the role of SVs in the NOdrCl, we made whole cell voltage-clamp recordings of cultured
ACs. After 8 days in culture, ACs form functional GABAergic synapses with each other similar
to GABAergic synapses in the intact retina [25, 26]. This simplified system allows for the
isolation of GABAergic synapses and the elimination of synapses from other cell types in the
intact retina. Our objective was to deplete the SV pool by driving exocytosis with depolarizing
voltage steps while inhibiting compensatory endocytosis pharmacologically. Dynamin is a key
player in endocytosis functioning as a GTP-dependent pinchase, driving fission of endocytosing
vesicles (Fig 2.1B). In mammals, there are three isoforms of dynamin (dynamin 1-3). Dynamin 1
is expressed at high levels in mammalian neurons [27]. Dynamin 2 is expressed ubiquitously
[28], and dynamin 3 is almost exclusively expressed in the mammalian brain and testis [29].
There is also evidence that all three isoforms are expressed in the developing rat brain [30, 31].
In the chicken, full predicted sequences for dynamin 1 and 3 have been identified while only a
partial predicted sequence is available for dynamin 2. However, dynamin 1 and 3 are highly
conserved between chicken and rodents (dynamin 1 rat 96%, mouse 94%; dynamin 3 rat 92%,
mouse 93%; scores are for identity). All three isoforms have the four domains of dynamin: a
GTPase domain, a plextrin homology domain that interacts with membrane lipids, a GTPase
effector domain involved in assembly [32, 33], and a proline-rich domain [34-36]. Dynasore
interferes with the GTPase activity of dynamin during endocytosis [37]. The more potent
dynasore analogs dyngo 4a [38] and dynole 34-2 [39] also target the GTPase activity of dynamin.
MiTMAB targets the plekstrin homology domain of which interacts with membrane lipids and
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assists in vesicle fission [40]. Our findings reveal that the dynamin inhibitors reduce endocytosis
in ACs and two of them (dynasore and dyngo-4a) interfered with the NOdrCl. However, we have
also discovered that the dynamin inhibitors can alter voltage-dependent Ca2+ signaling, voltagegated Ca2+ currents and synaptic transmission. Interestingly, the clathrin inhibitor Pitstop 2 also
reduced the NOdrCl suggesting that disruption of endocytosis is at least one factor involved in
the inhibition of the NOdrCl.

Methods
Cell Culture: Eight-day chick embryo eyes were removed, the retinas dissociated and
cultured as previously described [4]. The use of 8-day old chicken embryos was determined to be
exempt by the LSU Institutional Animal Care and Use Committee (IACUC). Cell cultures were
maintained under 5% CO2 atmosphere at 37ͦ C. ACs that had been in culture for 9-13 days
(embryonic equivalent days 17-21) were used for experiments because AC-AC GABAergic
synapsis are functional from embryonic equivalent day 16 onwards. ACs used for
electrophysiology and live-cell imaging experiments were identified based on morphology as
previously described [25].
Electrophysiology: Culture dishes were mounted on the stage of an Olympus IX70
inverted microscope. A reference Ag/AgCl pellet electrode in 3M KCl grounded the dish via 1%
agarose bridge containing 3M KCl. Patch pipettes were pulled from thick-walled borosilicate
glass (O.D.:1.5mm, I.D.:0.86mm; Sutter Instruments, Novato, CA) using a P-97 Flaming/Brown
puller (Sutter Instruments). Patch pipette resistances were between 4-8 MΩ when measured in
the bath. Whole-cell recordings were performed using an Axopatch 1-D amplifier, Digidata
1322a digitizer, and pClamp 10.0 software (Molecular Devices, Sunnyvale, CA). External
solutions were continuously perfused (1.5-2 mL/min) using a pressurized 8-channel perfusion
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system (Automate Scientific, Berkeley, CA). Series resistance was measured but the series
resistance compensation options available in the program was not employed. Using pClamp
10.0, the junction potential was estimated to be -14.5 mV and -21.5 mV for ruptured patch and
perforated patch solutions, respectively. Voltage ramp data for determining Erev-GABA were
corrected for series resistance error and junction potential then subtracting the leak current (also
corrected) that was obtained from recording ramp currents in the absence of GABA. For autaptic
recordings, the ACs were not in contact with other neurons, ruling out the synaptic input from
unclamped cells. Charge transfer at autapses was calculated by integrating the area of leaksubtracted current following the depolarization step. The charge transfer integration (pA * s) was
then calculated and reported as pC as previously described [41]. Inward Ca2+ currents were often
contaminated and obscured by outward synaptic current during the voltage step (see Figures 2.5
& 2.11).
Solutions and Reagents: All reagents were purchased from Sigma-Aldrich, unless
otherwise indicated. The external solution used for electrophysiology experiments contained (in
mM): NaCl (116.7), KCl (5.3), Tetraethylammonium (TEA)-Cl (20), CaCl2 (6.0), MgCl2 (0.82),
HEPES (10.0), glucose (5.6). Tetrodotoxin citrate (TTX) (300 µM, Abcam, Cambridge, UK) was
added to external solutions to block voltage-gated Na+ channels. For GABA-gated current
recordings, the voltage-gated Ca2+ channel blocker La3+ (50 µM) was added to the external
solution. For recordings of the voltage-gated Ca2+ currents, 10 µM bicuculline was added to the
external solution to block GABAA receptors. The pH of external solutions was adjusted to 7.4
using HCl.
Internal solutions for perforated patch recordings contained (in mM): Cs
Methanosulfonate (135.0), CsCl (10.), MgCl (4.0), CaCl2 (0.2), EGTA (1.1), HEPES (10.0), and
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NaCl (1.0) and Amphotericin B (Calbiochem, San Diego, CA). Amphotericin B stock (54 mM)
was mixed and sonicated with Pluronic F-127 (2.5% w/v in DMSO, Life Technologies) in a 1:2
ratio. The Amphotericin B stock and pluronic mixture was vortexed and sonicated for 30 seconds
each then added to 5 mL of internal B solution for a final concentration of 200 µg/mL and kept
on ice during experiments. Internal solutions for ruptured patch recordings contained (in mM):
Cs Methanosulfonate (100), CsCl (10.0), CaCl2 (0.1), MgCl2 (2.0), HEPES (10.0) and EGTA
(1.1) in combination with an ATP regeneration system. The ATP regeneration system contained
50 lu/mL creatine phosphokinase, 20 mM creatine phosphate, 1 mM ATP disodium, 3mM ATP
dipotassium and 2 mM GTP. For experiments targeting dynamin GTPase activity, the GTPase
inhibitor GTP-γS (Sigma-Aldrich, St. Louis, MO) replaced GTP in the internal solution at 4 mM.
Internal solutions were filtered through a 0.2 µm Nalgene (Thermo Fischer Scientific, Waltham,
MA). The pH for internal solutions was adjusted to 7.4 using CsOH.
Dynamin inhibitors were prepared as 100 mM stocks in DMSO. Stocks were added to
external solutions, then mixed and sonicated for final concentrations of: dynasore (80 µM,
TOCRIS, Bristol, UK), MiTMAB (30 µM Abcam), dyngo 4a (30 µM, Abcam) and dynole 34-2
(10 µM, Abcam). A DMSO-only external solutions was used as a control. The actin
polymerization inhibitors Cytochalasin D (Enzo, Farmingdale, NY) and Latrunculin B (Enzo)
were mixed and sonicated with DMSO to make 100 mM stocks and added to the TEA external
solution. The final concentration of both inhibitors was 2 µM. For experiments measuring
autaptic currents, external solution with Li+ replacing Na+ was perfused just during collection of
the autaptic data to remove the contaminating current arising from the Na-Ca exchanger [42].
The time the cells were exposed to Li+ was kept as short as possible (4 sec) to minimize effects
due to inhibiting exchanger function. Additionally, CsCl was increased to 145 mM (by replacing
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Cs Methanesulfonate) in the internal solution in order to raise the equilibrium potential for Cland increase the driving force on Cl- when recording synaptic currents at -70 mV.
NO Solutions: NO solutions were prepared by bubbling Fisher® double-distilled pure
water with Argon for 20 minutes followed by bubbling with pure NO gas for 5 minutes. The NO
was then sealed and protected from light and stored at 4 ͦ C until use. NO (20-50 µL) was
injected into the perfusion line and has been estimated to reach the recorded cell in ~3s and to
remain for ~3-5s [1].
Fluorescence Imaging: The external solution used for imaging experiments contained (in
mM): KCl (5.37), NaCl (136.89), CaCl2 (3), MgCl2 (1), HEPES (3.02), and Glucose (5.5). The
lipophilic dye FM1-43 (4 µM, Life Technologies, Carlsbad, CA) was added to the imaging
external solution. Culture dishes were mounted on an Olympus IX70 inverted microscope
equipped with a sensicam QE CCD Camera (QImaging, Surrey, BC). After gaining electrical
access, cells were exposed to FM dye and, after voltage steps were delivered, the dye was
washed out for 1-2 minutes before continuing the experiment. All images were acquired with
Slidebook 5.0 software (3I, Denver, CO) and analyzed using Graphpad software (La Jolla, CA).
For Ca2+ imaging experiments, the cell permeable Ca2+ indicator Oregon Green 488
Bapta-1 AM (OGB, Thermo Fisher Scientific) stocks (2 mM) were combined with Pluronic F127 (2.4% w/v in DMSO, Life Technologies) in a 1:1 (µL) ratio, and sonicated. The 2 µL OGB
and Pluronic F-127 mixture was added to 1mL of Hank’s buffered salt solutions, vortexed, and
sonicated for a final concentration of 2 µM. Cells were incubated in the dark at room temperature
for 1 hour in the OGB/Pluronic/HBSS mixture then rinsed with normal imagine external
solution. Images were captured every 3 seconds with an exposure time of 1 second. Data were
gathered from regions of interest in cell bodies. A high K+ solution (50 mM) was perfused onto
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the cells for 6 seconds to depolarize the cells and activate voltage-gated Ca2+ channels. The
effects of the inhibitors were independent of the order of presentation. Mean fluorescence
normalized to the resting fluorescence (F/F0) in all imaging experiments was calculated by
averaging the regions of interest (ROI) mean fluorescence for the first 15 time points before
exposure to K+ and then dividing all the other values by that number. Images and data acquisition
were acquired using Slidebook 5.0 software.
Immunocytochemistry: ACs were grown on glass coverslips for 8 days in culture and
then fixed in 2% paraformaldehyde for 30 minutes at 4 ͦ C in a blocking solution containing
dilution solution (PBS, 1% bovine serum albumin, 0.5% saponin) with 5% normal goat serum.
We employed primary polyclonal antibodies raised against rabbit CFTR (Catalog no. ab131533;
Abcam). We have previously characterized this antibody with a western blot showing a single
band at the appropriate molecular weight [7]. CFTR antibodies were diluted at 1:1000 in dilution
solution and applied to cells at 4 ͦ C overnight then washed with PBS. Secondary goat anti-rabbit
DyLight 488 antibody (no. 355553; Thermo Fisher Scientific) was diluted to 1:500 in dilution
solution. Cells were incubated for 1 hour at room temperature in secondary antibodies then
washed in PBS. Secondary antibody-only controls were prepared in the same solutions and
produced no labeling [7]. The primary monoclonal antibody raised against SV2 developed by
K.M. Buckley of Harvard Medical School was obtained from the Developmental Studies
Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa,
Department of Biology, Iowa City, IA 52242. This antibody has been demonstrated to be
effective in chicken tissue according to the product information from Developmental Studies
Hybridoma Bank. Supernatant was diluted at 1:2 and incubated at room temperature for 1 hour.
Secondary goat anti-mouse Dylight 550 antibody (Thermo Fisher Scientific) was diluted to
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1:1000 in dilution solution. Cells were incubated again at room temperature for 1 hour then
washed in PBS. No non-specific labeling was observed in secondary-only controls. After
washing, cells were mounted in Prolong Diamond Antifade mounting medium (Thermo Fisher
Scientific). Cells were viewed on an Olympus IX70 microscope equipped with epifluorescence.
Images were acquired using Slidebook 5.0.
Data Analysis: Data from electrophysiology recording were analyzed using Clampfit 10.0
software, and plotted in Origin 8.0 (OriginLab, Northampton, MA). Imaging data were analyzed
using Slidebook and Origin and plotted in Origin. Data are reported as means ± SD. Statistical
analyses were done GraphPad Prism 6 (GraphPad Software, La Jolla, CA) using the paired and
unpaired student’s t-test, and one-way analysis of variance [43], Tukey honest significant
difference post hoc as appropriate. The Pearson’s R coefficient indicates an association between
two variable, with a range of -1 to +1. Levels of significance are represented as *p < 0.05, **p <
0.01, ***p < 0.001, ****p < 0.0001.

CFTR Expression At Putative Synapses
We have demonstrated that CFTR expression and function is required for the NOdrCl [7].
We began here by testing whether the CFTR protein was localized to the same regions of the cell
as SV2, a synaptic vesicle marker protein. In cultured ACs, the anti-CFTR antibody labeling
overlapped with populations of vesicles labelled with SV2. Co-labelling was observed at sites of
extensive process contact, which can indicate synaptic sites. (Fig 2.2). The mean Pearson’s Rvalue from 48 regions of interest in amacrine cell processes was 0.38 ± 15 which indicates a
positive correlation for the expression of CFTR and SV2. This co-localization suggests that
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CFTR might be expressed on SVs. These results support the hypothesis that NOdrCl via CFTR
activity on SVs could contribute to the elevation in cytosolic Cl-.

Figure 2.2: CFTR co-localizes with a synaptic vesicle protein. A. Polyclonal anti-CFTR
antibody labels retinal amacrine cell bodies and processes. Arrows indicate a region where
multiple AC processes are in contact, possibly a synaptic region (arrows). B. Anti-Sv2 labeling is
found throughout the cells, but is especially strong in regions of process contact (arrows). C.
Merged images of CFTR and SV2 labeling shows strong co-localization in the region of process
contact. Scale bars are 10 µm.
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Activating Voltage-Gated Ca2+ Channels Promotes Endocytosis
To test the role of SVs in NOdrCl release, we sought to stimulate the synaptic vesicle
cycle via depolarization under control conditions and in the presence of inhibitors of dynamindependent endocytosis. We hypothesized that inhibition of endocytosis under these conditions
would preferentially deplete presynaptic vesicle pools and allow us to determine the contribution
of SVs to NOdrCl. Synaptic vesicle exocytosis and subsequent endocytosis were achieved by
activating voltage-gated Ca2+ channels. The voltage-gated Ca2+ expressed in cultured ACs and
mediate neurotransmitter release are predominately L-type [43] and are susceptible to Ca2+dependent inactivation [42]. Perforated-patch recordings were made to preserve the cytosolic
environment for Ca2+-dependent inactivation was minimized (Fig 2.3A). To verify that the SV
cycle was stimulated effectively, we delivered the voltage-steps in the presence of FM1-43, a
tracker of endocytosis [44]. Increases in FM1-43 fluorescence in both cell bodies and processes
were observed, indicating that the SV cycle was effectively activated and that the voltage steps
promoted endocytosis throughout the cell (Fig 2.3B-D). (Mean % fluorescence change in cell
bodies: control, 21.9 ± 8.0, stimulated, 41 ± 18, n=6, p=.0013; processes: control, 11.8 ± 3.6,
stimulated, 22.1 ± 4.2, n=8, p=.0004 paired t-test, Fig 2.3E).
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Figure 2.3: Voltage steps elicit endocytosis. A. Perforated-patch recording from a representative
AC. The voltage was stepped from -70 mV to +10 mV for 100 msec and delivered 15 times with
a 3 second delay between the steps. Currents resulting from all 15 voltage steps are shown.
(Bottom) Scale bars are 100 pA and 50 ms. B, Another AC being recorded in the perforated
patch configuration. C. Cells were exposed to the lipophilic dye FM1-43 (4 μM) for two minutes
then imaged to establish a baseline control. D. An image after the series of voltage steps.
Labelling can be seen in the cell body and in processes. Scale bars are 15 μm. E. Mean %
fluorescence change ± SD. (paired t-test: cell bodies n = 6, p=.0013; processes n = 8, p=.0004).
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Dynamin Inhibitors Suppress Activity-Dependent FM1-43 Labeling
To explore the role of SVs in the NOdrCl, the effects of dynasore [37] [45], Dyngo 4a
[38], Dynole 34-2 [39] and MiTMAB [40, 46] were examined. The effectiveness of each of these
pharmacological reagents as endocytic inhibitors was evaluated by testing the effects of each
inhibitor on the voltage-dependent labeling with FM1-43. ACs were recorded in the perforated
patch configuration. Control images were captured before the voltage steps but after 2 min
exposure to both FM1-43 and a dynamin inhibitor. Images were taken again after the voltage
steps to +10 mV (15 steps, 100 ms) in the presence of either dynasore (80 µM), dyngo 4a (30
µM), dynole 34-2 (10 µM), or MiTMAB (30 µM). All of the inhibitors were effective in
suppressing the accumulation of FM1-43 fluorescence following voltage steps (Fig 2.4A-D)
Dynasore cell bodies: control 81.3 ± 1.2%, stimulated -14.3 ± 2.7%; Dynasore processes 79.3 ±
5.1%, stimulated -8.9 ± 2.9%; dyngo 4a cell bodies: control 57.2 ± 15.8%, stimulated 1.02 ±
0.5%; dyngo 4a processes control 65.9 ± 13.9%, stimulated 4.7 ± 7.3; dynole 34-2 cell bodies:
control 75.1 ± 3.2%, stimulated 56.5 ± 4.0%; dynole 34-2 processes 69.8 ± 2.5%, stimulated 39.6
± 2.2%; MiTMAB cell bodies: control 78.9 ± 7.2%, stimulated 15.1 ± 3.0%; MiTMAB processes
control 80.3 ± 8.9%, stimulated 13.2 ± 2.6%). The control fluorescence images of the ACs
exposed to dynasore were, on average, brighter than control images, suggesting a higher level of
constitutive endocytosis in dynasore and generating a net loss of fluorescence after the voltage
steps (Fig 2.4A).
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Figure 2.4: Dynamin inhibitors are effective in limiting activity-dependent FM1-43 labeling. AD, Mean percent fluorescence change for cell bodies and processes for each of the dynamin
inhibitors tested. Dynasore (but not the other inhibitors) increased baseline fluorescence such
that after the voltage steps, the FM1-43 fluorescence was lower than control values giving rise to
negative percent change in fluorescence. (Cell bodies: control n = 6; dynasore n = 6, p < .0001;
dyngo 4a n = 10, p < .0001; dynole 34-2 n = 10, p < .0001; MiTMAB n = 6, p < .0001.
Processes: control n = 6; dynasore n = 12, p <.0001, dyngo 4a (30 μM), n = 12, p < .0001; dynole
34-2 (10 μM) n = 10, p < .0001; MiTMAB (30 μM) n = 12, p < .0001, unpaired t-tests.)
Voltage Steps Alone Can Reduce The Synaptic Vesicle Pool.
From the FM1-43 experiments (as shown in Fig 2.3), we know that voltage steps (15, -70 mV to
+10 mV for 100 msec) were sufficient to stimulate exocytosis and subsequent endocytosis. To
determine whether this same voltage step protocol was effective in depleting SVs in the absence
of inhibition of endocytosis, we examined the postsynaptic responses of ACs before and after
voltage steps alone. ACs in culture make synapses with other ACs. When isolated, they can also
form autapses (Fig 2.5A). To examine whether repeated voltage steps can deplete SVs, we tested
the autaptic currents before and after the voltage step protocol described in Figure 2.3A. Delivery
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of these voltage steps causes a reduction in the autaptic currents when compared to control (Figs
2.5B-C).

Figure 2.5: Voltage steps alone can reduce the SV pool at autapses. A. A depiction of an AC
with an autaptic synapse. B. Autaptic synapses are activated by a single 100 msec voltage step
from -70mV to +10mV in the perforated patch configuration. Outward autaptic currents during
the voltage step to +10 mv are contaminated with inward voltage-gated Ca2+ currents.
Contamination from the electrogenic inward Na/Ca exchange current after the voltage step is
removed by replacing extracellular Na+ with Li+. The total time of exposure to Li+ is 4 seconds
(black bar). After 15 voltage steps, the asynchronous phase of synaptic transmission is reduced
(C). Scale bars are 25 pA and 100 ms. D. Mean charge transfer is plotted. (n = 7, p=0.0368,
paired t-test).
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During the voltage step to +10 mV, the inward voltage-gated Ca2+ currents and the outward
synaptic currents contaminate each other, so synaptic currents were quantified from the end of
the voltage step to the end of the record (Fig 2.5D). (Mean charge transfer (pC). Control 247.9 ±
46.5 pC; Post steps 203.3 ± 19.1 pC, n = 7, p =0.0368, paired t-test). These data indicate that the
voltage steps alone can partially deplete SVs.

Voltage Steps Are Not Sufficient To Block NOdrCl.
Because voltage steps can apparently stimulate enough exocytosis to reduce the SV pool,
we tested whether voltage steps alone were sufficient to block NOdrCl. To evaluate the effects of
the voltage step protocol on the NOdrCl, we combined a voltage ramp protocol to measure ErevGABA

with the voltage-gated Ca2+ channel-activating voltage step protocol to initiate the synaptic

vesicle cycle (Fig 2.6A). The voltage step protocol alone did not affect the NOdrCl. (Mean NOinduced shift (mV). Control 21.3 ± 6.1 mV; Post steps 24.7 ± 8.2 mV) (Figs 2.6B-D). Taken
together, these data suggest that although the voltage steps can reduce the SV pool, that alone is
not sufficient to block the NOdrCl.
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Figure 2.6: Voltage steps alone do not block NOdrCl. A. Schematic of the voltage ramp
protocol. B and C. Currents elicited by voltage ramps in the presence of GABA are plotted from
a representative AC recorded in the perforated patch configuration. Not shown are the ramp
currents collected in the absence of GABA for the purpose of leak subtraction or the GABAgated currents in response to voltage ramps collected prior to addition of NO. In this cell, the
NOdrCl is larger after delivery of the voltage steps. D. On average, however, there was no
significant difference in the amplitude of the shift before and after the voltage steps (paired t-test:
n = 11, p=0.2796).
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Dynasore And Dyngo 4a Block The NOdrCl
To determine whether inhibition of endocytosis with dynamin inhibitors would affect the
NOdrCl, GABA-gated ramp currents were measured before and after the voltage steps under
control conditions and in the presence of one of the four inhibitors. Dynasore and MiTMAB
were applied acutely (Fig. 6A). Under control conditions, the NOdrCl was observed (Fig. 6C).
The NOdrCl was also observed in control experiments when DMSO-alone was perfused onto
cells (not shown, 30.1 ± 19.2 mV, n=4). However, the NOdrCl did not occur when the voltage
steps and subsequent voltage ramps were delivered in the presence of dynasore (80 µM, Figs
2.7D, E and I). The effects of dynasore were partially reversible (Fig 2.7E, Mean NO-induced
shifts in Erev-GABA, dynasore: control 32.9 ± 4.6 mV, dynasore post steps 0 ± 0 mV). When ACs
were exposed to MiTMAB (30 µM) during the voltage steps and subsequent voltage ramps the
NOdrCl persisted (Figs 2.7F and I) MiTMAB: control 30.3 ± 11.6 mV, MiTMAB post steps 29.9
± 7.1 mV).
Dyngo 4a and dynole 34-2 generally require pre-incubation due to their slower inhibitory
effects on GTPase activity [38, 40]. For these experiments ACs were exposed to dyngo 4a (30
μM) or dynole 34-2 (10 μM), for 20 minutes prior to recording and the reagents remained during
the entire recording (Fig 2.7B). In the presence of dyngo-4a, but before the voltage steps,
injecting NO caused a transient shift in the reversal potential of the GABA-gated current (Fig
2.7H). After the voltage steps, however, dyngo 4a blocked the NOdrCl (Figs 2.7G, H and I,
dyngo 4a: control 21.7 ± 4.0 mV, dyngo 4a post steps 3.0 ± 2.7 mV). This dependence upon the
voltage steps, suggests that Ca2+-dependent exocytosis was required along with the inhibitor.
Dynole 34-2 was ineffective in inhibiting the shift in Erev-GABA (Fig 6I, dynole 34-2 control 30.9
± 19.1 mV, n=5; dynole 34-2 post steps 30.0 ± 11.2 mV).
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Figure 2.7: Dynasore and dyngo-4a inhibit the NO-dependent shift in Erev-GABA. A and B,
Schematics of the dynasore (80 µM) and MiTMAB (30 µM) (acute exposure) and the dyngo 4a
(30 µM) and dynole 34-2 (10 µM) (20 min pre-incubation) experimental protocols, respectively.
Not shown are the ramp currents collected in the absence of GABA for the purpose of leak
subtraction or the GABA-gated currents in response to voltage ramps collected prior to addition
of NO. C. Ramp currents recorded from an AC in the perforated patch configuration before and
after (red trace) exposure to NO. D. Data from the same cell as in C after exposure to dynasore.
E. Erev-GABA for a different cell is plotted over time, and shows that the NO-dependent shift in
Erev-GABA can be reversed. F. GABA-gated currents in response to voltage ramps are shown for a
representative AC exposed to MiTMAB reveal that this inhibitor does not block NO-dependent
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shift in Erev-GABA. G. Data plotted were recorded after the voltage step protocol and in the
presence of dyngo 4a. These data show that no shift occurred after NO application (red trace).
H. EGABA is plotted over the time course of the experiment for the same cell as shown in G. I.
Quantified means ± SD the of NO-induced shifts of all inhibitors. (Dynasore n = 12, p < 0.0001;
dyngo 4a n = 6, p < 0.0001; MiTMAB n = 5, p = 0.4933; dynole 34-2 n = 7, p=0.89 Unpaired ttests).

Dynamin Inhibitors Affect Voltage-Dependent Ca2+ Signaling.
Although dynasore, dyngo 4a and dynole 34-2 are all known to inhibit dynamin’s GTPase
activity, only dynasore and dyngo 4a inhibited the NOdrCl. Off-target effects have been
demonstrated for dynasore [45]. It has been shown that dyngo 4a and dynole 34-2 are more
potent and less cytotoxic than dynasore, however, off-target effects of dyngo 4a & dynole 34-2
are not yet known. There is evidence, however, that MiTMAB can inhibit voltage-gated Ca2+
channels required for exocytosis in rat adrenal chromaffin cells [47].
To address the possibility that the dynamin inhibitors were affecting some aspect of Ca2+
signaling, we performed imaging experiments on ACs loaded with the Ca2+ indicator Oregon
Green 488 BAPTA-1 (OGB) to investigate the effects of all the dynamin inhibitors on voltagedependent Ca2+ increases. In these experiments, a high K+ solution (50 mM) was perfused into
the culture dishes for 6 seconds to depolarize the cells and activate voltage-gated Ca2+ channels.
Dyngo 4a, dynole 34-2, dynasore, and MiTMAB were applied in addition to the high K+
depolarization, and all reduced the OGB fluorescence increase (Fig 2.8). (Mean F/F0. Control
for dynasore: 1.80 ± 0.04, dynasore 1.73 ± 0.08; Control for dyngo 4a 1.7 ± 0.03, dyngo 4a 1.4 ±
0.1; Control for MiTMAB 1.75 ± 0.01, MiTMAB 1.59 ± 0.02; Control for dynole 34-2 1.55 ±
0.04, dynole 34-2 1.42 ± 0.03). Although dyngo 4a and dynole 34-2 were applied acutely in
these cells, we did pre-incubate separate cells in the inhibitors (as in Fig 2.7) and also saw a
reduction in the OGB fluorescence when compared to untreated control cells (Data not shown,
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Mean F/F0 ± SD. Control for dyngo: 1.3 ± 0.05, n=44; dyngo 4a 1.2 ± 0.02; control for dynole
34-2: 1.55 ± 0.03, n=44; dynole 34-2 1.04 ± 0.02). In some cells, the effect of the inhibitors in
high K+ were tested before the control depolarization in order to detect any inhibitor-independent
effects on the Ca+2 signal amplitude over time. No such effects were observed.
In ACs, voltage-gated L-type Ca2+ channel activity initiates neurotransmitter release [42,
48, 49]. To examine whether these dynamin inhibitors affect L-type Ca2+ channel currents, we
used voltage ramps to elicit voltage-gated Ca2+ current (Fig 2.8). Because the amplitude of
voltage-gated Ca2+ currents are variable in these cells, we only tested the acute effects of the
inhibitors to allow for “within cell” comparisons. Dynasore, dynole 34-2 and MiTMAB
significantly reduced the peak amplitude of the Ca2+ current (Mean peak amplitude (pA).
Dynasore control -76.0 ± 16.2 pA, dynasore -11.2 ± 20.4 pA; dyngo 4a control -50.5 ± 30.8 pA;
dyngo 4a -60.0 ± 41.9 pA, dynole 34-2 control -130.3 ± 22.6 pA, dynole 34-2 -31.6 ± 6.3 pA;
MiTMAB control -118.1 ± 19.7 pA. MiTMAB -52.2 ± 2.3 pA) (Fig 7E-G). The inhibitors did
not affect the voltage-dependence of the Ca2+ current. These data demonstrate that the Ca2+
channels expressed by ACs can be inhibited by some dynamin inhibitors. We observed that the
effects on Ca2+ currents were more dramatic than the effects on voltage-dependent Ca2+
elevations, suggesting that Ca2+ release from stores plays a substantial role in the Ca2+ elevations.
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Figure 2.8: Dynamin inhibitors interfere with voltage-dependent Ca2+ signaling and voltagegated Ca2+ currents. A-D, (Left) Ca2+ imaging data from OGB 488-loaded (1 µM) ACs. A 50
mM K+ -induced depolarization causes an increase in OGB fluorescence, which indicates an
increase in [Ca2+]. Acute exposure of dynasore, dyngo 4a, dynole 34-2 and MiTMAB all reduce
the voltage-dependent Ca2+ increases. Mean quantified F/F0 ± SD. Data collected from regions of
interest (ROIs) in cell bodies. (Control and dynasore, n = 44; p < 0.05; Control and dyngo n =
56; p < 0.0001; Control and MiTMAB n = 44, p< 0.0001; control and dynole 34-2, n = 63, p <
0.0001, paired t-tests). E. Schematic of the voltage ramp protocol used to elicit voltage-gated
Ca2+ currents. Cells in the ruptured patch configuration were voltage-clamped at -70 mV for 500
ms. Then the voltage was stepped briefly down to -90 mV, ramped to +50 mV, and then back
down to -70 mV. F, Representative voltage-clamp recordings from four representative ACs.
Dynasore, dynole 34-2, and MiTMAB reduce the peak amplitude of the Ca2+ currents and the
effects were at least partially reversible. G, Mean peak amplitudes are plotted for four
populations of cells (dynasore n = 6, p=.0009; MiTMAB n = 5, p<0.01; dynole 34-2 n = 5,
p<0.01; dyngo 4a n = 5, p=0.5, paired t-tests).
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Actin Disrupters Do Not Affect The NOdrCl.
In addition to its role in endocytic fission, dynamin interacts with and regulates actin filaments,
[48, 51] which has the potential to regulate numerous other cellular functions [49]. Interestingly,
F-actin has been shown to directly interact with CFTR [50, 52] and to regulate its function [53].
Thus, a dynasore-mediated disruption in actin filament regulation might also affect the function
of CFTR, a key player in NOdrCl. To determine whether disruption of actin regulation underlies
the inhibition of NOdrCl by dynamin inhibitors, we employed two actin polymerization
disruptors Cytochalasin D [54, 55] and Latrunculin B [56]. ACs were pre-incubated in either
Cytochalasin (4 μM) or Latrunculin B (4 μM) for 45 minutes (Fig 2.9A) and the inhibitors were
present during the recordings. NO-dependent shifts in Erev-GABA persisted in cells pre-treated with
the inhibitors. When compared to control cells recorded on the same day, there were no
significant difference in the shift amplitudes for ACs recorded in the presence of the inhibitors
(Mean NO-induced shift (mV). cytochalasin control 21.5 ± 8.3 mV, cytochalasin D 27.5 ± 17.1
mV; latrunculin B control 21.4 ± 4.2 mV, latrunculin B 20.2 ± 1.1 mV) (Fig 2.9B-C). These data
suggest that dynasore and dyngo 4a are not inhibiting the NOdrCl by altering dynamin’s
interaction with actin.
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Figure 2.9: Dynamin inhibitors do not block the NOdrCl via disruption of actin. A, Cartoon of
experimental setup. In control cells, voltage ramps were delivered in the perforated patch
configuration before and after injections of NO in normal external solution. Other ACs were pretreated with either Cytochalasin D (4 µM) or Latrunculin B (4 µM) for at least 45 minutes. B.
and C. left. Leak-subtracted GABA-gated currents reveal a shift in Erev-GABA after NO (red trace)
in representative ACs recorded in either cytochalasin D (B) or latrunculin B (C). Mean NOinduced shifts ± SD. (Cytochalasin D, n = 7; p=.4138, Latrunculin B, n = 6, p=.4368, unpaired ttests).

46

GTP-γS Does Not Affect The NOdrCl.
If dynasore and dyngo-4a block the NOdrCl by interfering with the GTPase function of dynamin,
then we might be able to mimic the effect with a general inhibitor of GTPase function. GTP-γS is
a non-hydrolysable analogue of GTP that can function as a GTPase inhibitor [57]. GTP-γS (4
mM) replaced GTP in the ATP regeneration system of the internal solution. With GTP-γS in the
pipet, ruptured-patch recordings were only viable for up to about 5 minutes. After gaining access
to the cell with GTP-γS in the pipet, the voltage ramp protocol shown in Figure 2.6A was
delivered and the NO-dependent shift in Erev-GABA was observed. This representative trace was
collected about 4 minutes after gaining access to the cell. (Figs 2.10A and B) (Mean NO-induced
shifts ± SD. Control: 16 ± 4.0 mV. GTP-γS: 16.1 ± 5.3 mV. n=7, Unpaired t-test).
The effects of GTP-γS were also tested under conditions of active exocytosis and endocytosis.
Voltage ramps in the presence of GABA were delivered before and after injections of NO,
followed by the voltage step protocol previously described, and then the ability of NO to shift
Erev-GABA was re-tested. At least on this time frame (about 5 minutes total time since gaining
electrical access to the cell), GTP-γS did not block the NO-dependent shift in Erev-GABA. (Figs
2.10C-E) (Mean NO-induced shift ± SD, Control: 10.2 ± 0.9 mV, Post Steps 11.7 ± 1.2 mV, n =
3, p=0.0919, unpaired t-test). Recordings were also made in the ruptured patch configuration
using a GTP-free internal solution and the NOdrCl was not blocked (data not shown, 20.1 ± 2.5
mV, n=4). Due to the limited duration of the recordings in these experiments, the possibility
remains that GTP-γS may have incompletely filled the neuronal processes. These data, however,
do raise the possibility that dynasore and Dyngo-4a, both of which are thought to function via
GTPase inhibition, are inhibiting endocytosis and the NOdrCl by some other mechanism.
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Figure 2.10: GTP-γS does not mimic the effects of dynasore and dyngo 4a on the NOdrCl. A. In
the ruptured patch configuration, GTP-γS (4 mM) replaced GTP in the ATP regeneration system
to function as a general GTPase inhibitor. About 4 minutes after gaining access to the cell,
voltage ramps were delivered before and after injections of NO and the NO-dependent shift in
Erev-GABA was still observed. B. Mean NO-induced shifts ± SD (Unpaired t-test: control n=7,
GTP-γS n = 7). C. In separate cells, voltage ramps were delivered before and after injections of
NO 4 minutes after rupturing the patch. Then voltage steps were delivered to stimulate exo- and
endocytosis, followed by another set of voltage ramps and NO. The NO-dependent shift in ErevGABA remained. D. Erev-GABA is plotted over the time course of the experiment for the cell shown
in C. E. Mean NO-induced shifts ± SD. (paired t-test: n = 3, p=.3625).
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Dynasore Affects Neurotransmitter Release From ACs.
Dynasore has been shown to increase the probability of evoked transmitter release at the frog
neuromuscular junction and to increase spontaneous synaptic event frequency in the nucleus of
the solitary tract neurons [58, 59]. If dynasore similarly affects presynaptic function in ACs, then
this might contribute to the inhibitory effect of dynasore on the NOdrCl. To determine whether
AC synaptic exocytosis was altered by dynasore, we tested its effects on autaptic currents (Figs
2.11A-C). Dynasore increased the asynchronous postsynaptic currents (Fig 2.11D). (Mean
charge transfer ± SD: Control 245.1 ± 35.9 pC; dynasore post steps 464.9 ± 107.2 pC) indicating
that dynasore promotes synaptic exocytosis from ACs.
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Figure 2.11: Dynasore promotes neurotransmitter release at amacrine cell autapses. A, A
depiction of an AC in with an autaptic synapse. B, Autaptic synapses are activated by a single
100 msec voltage step from -70 mV to +10 mV recorded in the perforated patch configuration.
Autaptic currents during the voltage step are contaminated with the voltage-gated Ca2+ currents.
Contamination from the electrogenic inward Na/Ca exchange current after the voltage step is
removed by replacing extracellular Na+ with Li+. The total time of exposure to Li+ is 4 seconds
(black bar). C, After 15 voltage steps in the presence of dynasore, autaptic currents reveal
enhanced neurotransmitter release. D, Mean charge transfer ± SD. (n=6, p=.0063, paired t-test).
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Pitstop 2 Inhibits The NOdrCl.
The effects of dynasore and dyngo 4a on the NOdrCl are consistent with a role for SVs as a
releasable source of Cl-. However, the additional effects of these compounds that we describe
here as well as the inability of GTPγS to mimic the effects of dynasore and dyngo 4a make a
conclusion difficult to draw. Therefore, we sought to inhibit endocytosis by an alternative
mechanism. Pitstop 2 can inhibit the interactions between clathrin and adapter proteins that are
required for clathrin coat assembly [61] although it has been demonstrated to inhibit clathrinindependent endocytosis as well [62]. To determine whether Pitstop 2 was effective in inhibiting
endocytosis, we combined this reagent with the voltage and imaging protocol used in Figs 2.3
and 2.4. Pitstop 2 inhibited voltage-dependent FM1-43 fluorescence increases (Cell bodies
control 61.5 ± 16.6%, Pitstop 2 1.1 ± 0.05%; processes control 54.9 ± 15.0%, Pitstop 2 1.1 ±
0.03%) (Fig 2.12A). The effectiveness of Pitstop 2 in inhibiting the NOdrCl was tested by
repeating the experiment shown in Figure 2.5A but delivering the voltage steps in the presence of
Pitstop 2 rather than the dynamin inhibitors (Fig 2.12B). Pitstop 2 inhibited the NOdrCl by about
50% (Mean NO-induced shift in Erev-GABA ± SD. Control: 19.3 ± 2.0 mV; Pitstop 2: 8.1 ± 1.3
mV, n=7, p<.0001, paired t-tests) (Figs 2.12C-E). The ability of another endocytosis inhibitor
that functions by a completely different mechanism suggests that depletion of the SV pool
reduces the sources of Cl- during NOdrCl.
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Figure 2.12: Pitstop 2 reduces the NO-dependent shift in Erev-GABA. A. Mean percent
fluorescence change for cell bodies and processes in the presence of Pitstop 2 (20 µm). The
clathrin inhibitor reduces voltage-dependent FM1-43 fluorescence increases, indicating that it is
an effective SV inhibitor (cell bodies, n = 9, p<0.0001; processes, n = 18, p<0.0001, unpaired ttest). B. Schematic of voltage ramp experiment. ACs were recorded in the perforated patch
configuration. C. and D. Representative trace of Erev-GABA measurements before and after voltage
steps in the presence of Pitstop 2. E. Mean NO-induced shifts ± SD. Pitstop 2 reduces the
NOdrCl. (n=7, p<0.0001, paired t-tests).

Discussion
We embarked on these experiments to determine whether SVs contribute to the cytosolic
Cl- elevations generated by NO. Our results demonstrate that dynamin inhibitors can block
endocytosis as measured by FM1-43 labeling and dynasore and dyngo 4a reduced or blocked the
NOdrCl. We also found that dynamin inhibitors can affect with Ca2+ signaling, voltage-gated
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Ca2+ currents, and synaptic transmission. Nonetheless, the clathrin inhibitor Pitstop 2 also
reduced the NOdrCl, suggesting that the disruption of SV endocytosis is one factor involved in
the inhibition of the NOdrCl by dynasore and dyngo 4a.
Although each of the dynamin inhibitors were demonstrated to inhibit endocytosis as
measured by FM1-43 labeling, dynole 34-2 and MiTMAB were the least effective. Similarly,
dynasore and dynole 4a were effective in blocking the NOdrCl whereas dynole 34-2 and
MiTMAB were not. It is possible that it is due to the particular isoform of dynamin that is being
inhibited, however, dynasore, dynole 34-2 and MiTMAB are effective on all three mammalian
isoforms of dynamin with only dyngo-4a showing a preference for dynamin 1 [63, 64]. Another
possibility is that the differences in effectiveness are due to species differences although the high
level of identity (>90%) between chicken and rodent dynamins makes this explanation less
likely. It has recently been demonstrated that at the neuromuscular junction, dynasore and
MiTMAB have distinctive actions on endocytosis where dynasore inhibited only an early phase
of endocytosis and MiTMAB inhibited only a late phase [65]. The stimulus conditions in those
experiments were much different than ours with exocytosis stimulated by 1000 action potentials
delivered at different frequencies. Our presynaptic stimulation involved 15 100 msec voltage
steps providing a total duration of depolarization of 1.5 sec whereas the duration of action
potential stimulation in Linares-Clemente et al. (2015) ranged from ~10-100 sec. Nonetheless,
their experiments reveal that MiTMAB might be an efficient inhibitor of dynamin only under a
specific set of circumstances. Although dynole 34-2 and MiTMAB were less effective in
inhibiting activity-dependent FM1-43, they still had significant effects. The lack of effect on the
NOdrCl suggests that the effect on the NOdrCl may have some sort of threshold component.
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Here, we provide evidence that dynamin inhibitors can alter Ca2+ signaling and synaptic
transmission in ACs. What is not clear is whether these are “off-target” effects in the sense that
they are not due to inhibition of dynamin function or are these effects due to inhibition of
dynamin functions that are thought to be unrelated to endocytosis? A well-established additional
function of dynamin is regulation of the actin cytoskeleton [51]. However, the other effects of
dynasore that we demonstrate might be due the actin-regulating role of dynamin. A functional
link between dynamin, the actin cytoskeleton and L-type Ca2+ channel activity has been
demonstrated for αT3-1 gonadotroph cells [66]. Signaling via activation of the gonadotrophin
releasing hormone receptor typically leads to cytoskeletal rearrangement, which they show is
required for normal activation of L-type Ca2+ channels in these cells. These results raise the
possibility that dynasore and dynole 34-2 might inhibit L-type activity in ACs via dysregulation
of the actin cytoskeleton. Regardless of the mechanism, inhibition of L-type Ca2+ channels does
not explain the effects of dynasore and dyngo 4a on the NOdrCl. First, dyngo 4a inhibited the
NOdrCl, but did not inhibit voltage-dependent Ca2+ currents. Additionally, inhibition of L-type
channels would minimize our ability to deplete synaptic vesicles so would likely lessen the
effects of the inhibitors on the NOdrCl.
We also show that dynasore increased evoked synaptic transmission at AC autapses.
Although dynasore has been shown to promote neurotransmitter release from the frog NMJ [58]
and in rodent nucleus of the solitary tract neurons [59], the effect there was to increase
spontaneous neurotransmitter release rather than evoked. At the NMJ the effect was partially
Ca2+-dependent and it was revealed that minutes-long exposure to dynasore also elevated basal
Ca2+ levels in terminals. In ACs, no Ca2+ elevations were observed in response to exposure to
dynasore or any of the other dynamin inhibitors arguing against a Ca2+-dependent effect,
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especially in light of the inhibitory effect of dynasore, dynole 34-2, and MiTMAB on AC Ca2+
current amplitude.
Pitstop 2 was developed by screening compounds for interference between the terminal
domains and known binding partners of clathrin such as amphiphysin and AP180 in vitro [61].
Since its development, Pitstop 2 has been used in a wide variety of preparations and has been
demonstrated to be an effective inhibitor of endocytosis, however, its mechanism of action in
vivo is a matter of debate [2]. It has been shown to inhibit both clathrin-dependent and
independent endocytosis [27, 62] which calls into question its predicted interactions with
clathrin. These and other observations have led to suggestions that Pitstop 2 actually interferes
with a step downstream from coat formation [2]. In hippocampal neurons Pitstop 2 was also
reported to affect vesicle acidification and mitochondrial pH, however these data were not shown
and the degree and nature of the alterations were not stated, making it difficult to evaluate the
importance of these potential effects in ACs [67]. Given these caveats, however, the consistency
of the effects of dynasore, dyngo 4a and Pitstop 2 in inhibition of [68] the NOdrCl suggest that
fully functional endocytosis is required for NO to elevate cytosolic Cl-.
Significance: Here, we report that NO, likely in the range of 100’s of nanomolar, initiates
release of Cl- and that this release is dependent upon endocytosis. What is the evidence that
these conditions actually occur in the retina? Imaging experiments using 4,5-diaminofluoroscein
(DAF) to detect NO production in slices of turtle retina demonstrate light-dependent DAF
signals are generated in subsets of cells throughout the retina [69]. Interestingly, DAF signals
were largely confined to the boundaries of the cell bodies and processes in ACs, whereas cells in
the ganglion cell layers had DAF signals that extended several microns away from the cell body.
This suggests that NO diffuses out of these cells. NO microelectrode measurements made just
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outside a DAF-positive cell in the ganglion cell layer detected NMDA-stimulated NO
concentrations of about 200 nM [69]. Presumably, the concentration in the cytosol is higher.
Furthermore, light stimulation of the retina within the physiological range results in Snitrosylation patterns that are intensity-dependent [70]. This is significant because Snitrosylation occurs over higher concentration ranges than does NO-dependent activation of
soluble guanylate cyclase which can occur in the low nanomolar to picomolar range [71].
Importantly, we have previously demonstrated that the NOdrCl operates independent of soluble
guanylate cyclase [1].
The involvement of SVs in the NOdrCl is especially relevant to AC function because
ACs participate in serial [72] and reciprocal synapses [21] such that presynaptic Cl- can affect
the sign of nearby incoming GABAergic synapses in a highly localized fashion [22-24]. We have
also recently demonstrated that the NO donor SNAP can increase spontaneous and evoked
GABA release via presynaptic activation of TRPC5 channels [41, 73] providing an additional
NO-dependent mechanism for enhancing GABAergic output from ACs. The impact of NO as an
enhancer of GABAergic output in cultured ACs supports the hypothesis that NO can increase the
GABAergic output onto ganglion cells in the retina. This effect of NO had been demonstrated in
dark-adapted ferret retina where ON and OFF light responses were recorded in ganglion cells
[74]. NO suppressed the light-dependent activity in both ON and OFF ganglion cells but the
effect was especially strong in the OFF pathway. Furthermore, this effect was thought to be due
to an increase in inhibitory output from ACs. Our results in ACs also have implications for NO
effects on GABAergic synapses elsewhere in the brain because we have demonstrated that
hippocampal neurons also have an NO-releasable store [1]. Understanding the mechanisms
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underlying the NO-dependent switch from inhibitory to excitatory input will make an important
contribution to our understanding of the flexibility of synaptic transmission in the CNS.
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Chapter 3. Conclusions
In the retina, the visual signal is initiated by rod and cone photoreceptors that detect light
and convert that detection into a change in synaptic output. Interneurons (bipolar, horizontal and
amacrine cells) shape the retinal signal before it arrives at ganglion cells where it is transmitted
via the optic nerve to higher visual centers in the brain [1]. Collectively, bipolar, horizontal, and
amacrine cells (ACs) process the retinal signal and generate specific responses to motion &
direction selectivity [2], ambient levels of light [3-7], and stimulus contrast [6, 8, 9]. For ACs,
the mechanisms by which these interneurons modulate synaptic transmission remains to be fully
understood., It has been well described that AC dendrites can regulate physiological activity
independently [10] and that the dendrites of starburst ACs modulate the electrical signal in a
localized manner [11] [12-14].
In retinal ACs, NO releases Cl- from acidic organelles (Krishnan & Gleason, 2015), in a
sGC- independent manner (Hoffpauir, 2006). While the effects of NO are transient, over a period
of seconds, it has been challenging to decipher precisely how NO induces internal Cl- release. A
limitation of the experiments conducted in Chapter 2, and perhaps a limitation of the entire
investigation of NOdrCl, is that we have yet to uncover the full mechanism by which NO can
cause Cl- release. A class of Ca2+-activated Cl- channels, the anoctamins, has been shown to
contribute to internal Cl- release [15]. It is possible that anoctamins also contribute to the
NOdrCl, along with the CFTR that we’ve demonstrated is a requirement for Cl- release in ACs
[16]. The role of anoctamins is currently being explored in our lab using RT-PCR,
immunocytochemistry and voltage clamp experiments similar to those described in Chapter 2.
Recognizing that the NOdrCl is dependent on CFTR expression and function [16] and
our observation of SV2 and CFTR immune-colocalization, we hypothesized that synaptic
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vesicles (SVs) may be a source of NO-releasable Cl-. The experiments employed in Chapter 2
primarily focused on targeting dynamin-dependent and clathrin-mediated endocytosis. We
considered the option of a dynamin mutant model however, because dynamin is involved in so
many aspects of normal cellular function, we anticipated that genetic knockdown of dynamin
would result in an broad array of defects that would be difficult to separate from the effects of
dynamin knockdown on endocytosis. Clearly, from my current work we know that even acute
pharmacological inhibition of dynamin has multiple cellular effects.
There were other limitations in some of my experiments. In the FM1-43 imaging
experiments, where all of the dynamin inhibitors were effective in reducing fluorescence, we can
only visualize SVs that have taken in dye at the cellular membranes and at synapses. This leaves
the possibility that SVs at some other internal stage of the SVs cycle could still be releasing Cl-.
We have performed imaging experiments aimed at targeting other acidic organelles. In
unpublished data, we combined Lysotracker, a lysosome indicator, and MQAE, a cytosolic Clindicator. We injected NO and measured MQAE’s decrease in fluorescence, which is an
indicator of a Cl- increase. However, we were unable to distinguish Cl- from fluorescent-tagged
acidic organelles.
Initially, we attempted to deplete SVs of luminal Cl- by removing external Cl- and
stimulating exocytosis and hopefully generating Cl- -depleted vesicles that could rejoin the
vesicular pool. These experiments yielded variable results, with some cells reflecting a larger
NO-dependent shift in Erev-GABA and others revealing a smaller shift. Unfortunately, we could not
measure whether all luminal Cl- was removed in this experimental. After voltage steps in 0 Clexternal solutions, we have to switch back normal Cl- solution to measure the GABA-gated
current. Therefore, it is possible that SVs, or some other internal store, is able to refill its Cl-
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supply relatively quickly. We have previously demonstrated that with multiple injections of NO
(greater than 10), the internal Cl- store can be depleted if the cells are recorded in Cl- -free
internal and external solutions (unpublished data). Therefore, under these conditions, the Clstore functions as a finite source of Cl- as one would predict. Under normal Cl- conditions,
however, luminal Cl- content is clearly more dynamic.
I also attempted a more precise method of assessing depletion of SVs by making dual
recordings from pairs of ACs in culture. We have previously shown that in paired recordings,
NO changes a small, hyperpolarizing postsynaptic current to a depolarizing current via the
NOdrCl [17]. We hypothesized that combining this protocol with dynamin inhibition would
inhibit the ability of NO to shift the reversal potential of postsynaptic currents specifically.
These experiments required voltage and inhibitor-dependent SV depletion in one direction (cell
A pre, cell B, post) then switching the direction (cell B pre, cell A post) to test the effect of the
SV depletion on the NOdrCl. Unfortunately, the strength of synapses between pairs of AC was
highly asymmetrical making these experiments prohibitively challenging.
The cultured AC model system allowed us to measure electrical activities of AC-AC
synapses. In future experiments, we could explore NO-dependent AC responses in retinal slices.
Recordings of ACs in retinal slices and measuring postsynaptic GABA-gated currents would
allow us to determine the effects of NO on the reversible potential of AC synaptic response.
Additionally, recordings from the output cells of the retina, the ganglion cells could also
contribute to our understanding of how NO affects different aspects of retinal signal processing.
For example, it would be beneficial to measure the effect of NOdrCl on the ON and Off
pathways, as well as the directional selectivity of ganglion cells. Taken together, these
experiments could reveal more about how NO affects visual processing.
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We have previously demonstrated that NO can induce internal Cl- release in hippocampal
neurons [17], therefore the NOdrCl is potentially widespread in the mammalian CNS.
Deciphering the mechanism by which Cl- is regulated at GABAergic synapses is imperative to
understanding inhibitory synaptic transmission as a whole in the CNS. It is plausible that the best
approach to working out this mechanism is by finding the Cl- transporters responsible. Our data
showing the requirement of CFTR [16], but not NKCC or KCC [17], in the NOdrCl is intriguing,
but the overall function of CFTR and the other co-existing Cl- co-transporters in neurons is
complex and still poorly understood. There is still much to learn about Cl- regulation in neurons.
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